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https://doi.org/10.1016/j.celrep.2020.107858SUMMARYDuring mammalian meiotic prophase I, programmed DNA double-strand breaks are repaired by non-cross-
over or crossover events, the latter predominantly occurring via the class I crossover pathway and requiring
the cyclin N-terminal domain-containing 1(CNTD1) protein. Using an epitope-taggedCntd1 allele, we detect a
short isoform of CNTD1 in vivo that lacks a predicted N-terminal cyclin domain and does not bind cyclin-
dependent kinases. Instead, we find that the short-form CNTD1 variant associates with components of the
replication factor C (RFC) machinery to facilitate crossover formation, and with the E2 ubiquitin conjugating
enzyme, CDC34, to regulate ubiquitylation and subsequent degradation of the WEE1 kinase, thereby modu-
lating cell-cycle progression. We propose that these interactions facilitate a role for CNTD1 as a stop-go
regulator during prophase I, ensuring accurate and complete crossover formation before allowing meta-
phase progression and the first meiotic division.INTRODUCTION
Meiosis is a specialized cell division consisting of one round of
DNA replication followed by two rounds of chromosome segre-
gation. During meiosis I, homologous chromosomes must pair,
synapse, and form crossovers to enable accurate segregation
at the first meiotic division (MI). During the second meiotic divi-
sion (MII), the paired sister chromatids segregate, resulting in
the formation of haploid gametes (Gray and Cohen, 2016).
Crossing over is achieved through meiotic recombination,
which is dependent on, and required for, accurate synapsis. Syn-
apsis is achieved by the formation of the synaptonemal complex
(SC), whose assembly and status defines the five sub-stages of
prophase I. Meiotic recombination is initiated by the formation of
programmed DNA double-strand breaks (DSBs) throughout the
genome in early leptonema (Baudat et al., 2000; Keeney et al.,
1997, 1999, Robert et al., 2016a, 2016b; RomanienkoandCamer-
ini-Otero, 2000). In the mouse, 200–300 DSBs are generated and
processed through common intermediate repair steps to yield
either non-crossover or crossover events (Gray and Cohen,
2016). While the majority of DSBs (90% in the mouse) repair as
non-crossovers in zygonema and early pachynema, the cross-
overs that form during pachynema establish the inter-homolog
tethers that allow for their correct segregation at MI (Cole et al.,
2014). Thus, the correct timing, frequency, and distribution of
crossovers ensures that at least one crossover per pair is gener-
ated (the obligate crossover) (Jones, 1984), that crossovers areThis is an open access article under the CC BY-Nmaintained at the expense of non-crossovers (crossover homeo-
stasis) (Cole et al., 2012; Martini et al., 2006), and that the forma-
tion of one crossover prevents the formation of nearby crossovers
(interference) (Jones and Franklin, 2006). How these rules are en-
forced within the realm of DSB repair and shape crossover and
non-crossover decisions remains unclear.
In the mouse, crossovers can form by at least two mecha-
nisms. The class I (ZMM) pathway is responsible for the majority
of crossovers and uses the DNA mismatch repair endonuclease
MutLg, a heterodimer of MLH1 and MLH3 (Edelmann et al.,
1996; Lipkin et al., 2002). MLH1 and MLH3 co-localize along
chromosome cores at a frequency of 23 foci at pachynema
(Baker et al., 1996), reflecting 90%–95% of the final crossover
count in male meiosis (Lipkin et al., 2002; Svetlanov et al.,
2008). The distribution ofMutLg foci during pachynema inmouse
spermatocytes is interference dependent and satisfies the
requirement for the obligate crossover (Broman et al., 2002).
Loss of either component of MutLg results in infertility due to
the loss of most crossovers, leading to arrest before metaphase
I in males and meiosis I non-disjunction in females (Baker et al.,
1996; Edelmann et al., 1996; Kolas et al., 2005; Lipkin et al.,
2002). The remaining 5%–10% crossovers are generated by
the class II MUS81-EME1-dependent pathway. These class II
crossovers are interference independent, but cannot account
for all of the class I-independent crossovers since the mutation
of both Mlh3 and Mus81 leads to the persistence of 1–3 chias-
mata (Holloway et al., 2008).Cell Reports 32, 107858, July 7, 2020 ª 2020 The Author(s). 1
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. CNTD1FH Protein Is Smaller Than Predicted, Lacking an N-Terminal Cyclin Homology Required for CDK Interaction
(A) Schematic of annotated full-length and short-form CNTD1, including predicted cyclin homology regions (red).
(B) WB using antibodies against the HA epitope and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) from testis lysate of Cntd1+/+, Cntd1FH/+, and
Cntd1FH/FH mice. The green arrow indicates the CNTD1-specific band.
(C) WB using the rabbit HA antibody against immunoprecipitated testis lysate from Cntd1FH/FH mice using rat anti-HA antibody. The green arrow indicates the
specific enriched band.
(D) WB using the anti-HA antibody against testis lysate from Cntd1+/+ and Cntd1FH/FHmice following normal and extended sonication. The green arrow indicates
the specific band.
(E) WB using the anti-HA antibody against yeast lysate expressing Cntd1 short-form and full-length Cntd1 from PADH1.
(legend continued on next page)
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OPEN ACCESSOne of the major questions in mammalian meiosis concerns
how crossovers are selected from the initial pool of 200–300
DSB repair intermediates. Initially, a subset (150) of these
repair intermediates accrue the MutSg heterodimer of MSH4
and MSH5 (Edelmann et al., 1999; Kneitz et al., 2000), an event
called crossover licensing. Of these, only 23–26 MutSg sites
subsequently become loaded with MutLg to form class I cross-
overs, while the remaining sites are repaired either through the
class II crossover pathway or via the formation of non-cross-
overs (Cole et al., 2014; Holloway et al., 2008; Milano et al.,
2019). The mechanism by which MutSg becomes further
selected by the accrual of MutLg has been called crossover
designation, leading to the idea that crossover homeostasis is
imposed sequentially by the association of these pro-crossover
MutS/MutL proteins (Cole et al., 2012; Hunter, 2015; Moens
et al., 2002).
Recent studies have revealed a number of regulatory mole-
cules that aid in crossover designation and that are essential
for class I crossovers, including crossover site-associated-1
(COSA1) in Caenorhabditis elegans (Yokoo et al., 2012) and its
mammalian ortholog cyclin N-terminal domain-containing-1
(CNTD1) (Holloway et al., 2014). Loss of COSA1 in worms results
in a failure to accumulate MSH-5 at DSB repair intermediates
and the loss of all crossovers (Yokoo et al., 2012). The loss of
CNTD1 in the mouse results in similar meiotic failure character-
ized by persistently elevated early crossover factors through pa-
chynema and failure to load crossover designation factors such
as MutLg, the crossover site-associated cyclin-dependent ki-
nase-2 (CDK2), and the putative ubiquitin E3 ligase HEI10 (Hollo-
way et al., 2014). In the present study, we sought to further eluci-
date the function of CNTD1 in driving crossover formation. We
generated a dual epitope-tagged allele of Cntd1 (Cntd1FH) to
facilitate the tracking of CNTD1 protein in mouse spermatocytes
and to enable the analysis of the CNTD1 interactome. We find
that CNTD1 localizes to sites that are loadedwithMutLg, but sur-
prisingly, the predominant form of CNTD1 in spermatocytes
lacks the ability to interact with known meiotic CDKs or cross-
over factors. Instead, CNTD1 drives crossover designation and
cell-cycle progression through distinct interactions with key reg-
ulatory complexes involved in facilitating the activity of MutLg
(namely replication factor C [RFC]) and those involved in modu-
lating cell-cycle progression through the ubiquitylation of critical
cell-cycle regulators (namely CDC34-containing SKP1-Cullin-
Fbox [SCF] complex).
RESULTS
Epitope Tagging of CNTD1 to Create a Cntd1FLAG-HA
Allele Reveals a Short-Form CNTD1
We used CRISPR-Cas9 to generate a dual C-terminal FLAG-
hemagglutinin (HA) epitope tagged allele (Figure S2A), called(F) N-terminal splice variants of mammalian CNTD1 homologs. Blue coloring de
immediate downstream amino acid sequences that follow colored black. In the
CNTD1 short form, respectively.
(G) Yeast two-hybrid with full-length CNTD1 and CNTD1 short form (bait) with CD
HIS-LEU-TRP).
(H) WB using antibodies against CDK2 and CDK4 from anti-HA IP of Cntd1FH/FHCntd1FH. The dual tag was placed at the 30 end of the protein,
preceding the stop codon. Cntd1FH/FH male mice are almost
indistinguishable from wild-type littermates (Figure S1).
Annotation of the Cntd1 genomic locus describes a 7-exon
gene encoding a 334-amino acid protein with a predictedmolec-
ular weight of 40 kDa for the full-length, tagged form (Figures
1A andS2A) (NCBI: NM_026562).Western blotting (WB) of whole
testis extracts from Cntd1+/+, Cntd1FH/+, and Cntd1FH/FH adult
matched littermates demonstrated the presence of the protein
specifically in mice bearing the Cntd1FH allele, but revealed a
smaller-than-expected band at 30 kDa, present only in the
testis (Figures 1B and S2B, arrow). Prior characterization of the
Cntd1 locus described the use of a start codon near the begin-
ning of exon 3 (NCBI: DS033671), which would produce a
27.5-kDa endogenous protein and a 29.7-kDa tagged protein,
matching the size we observe by WB (Figures 1A, 1B, and
S2A). We call this protein product CNTD1 short form. Since a
non-specific band around the predicted size (40 kDa) for
CNTD1FH is observed, we undertook immunoprecipitation (IP)
followed by WB using two independent anti-HA antibodies to
determine whether a form of Cntd1FH exists that is obscured
by this non-specific band. We observe the enrichment of the
smaller 30-kDa band in the IP fraction (Figure 1C, arrow), loss
of the non-specific band at 40 kDa, and no additional specific
bands (Figure 1C).
We considered the possibility that standard sonication for pro-
tein extraction may not sufficiently liberate proteins associated
with dense chromatin (T. Tran and J. Schimenti, personal
communication). To determine whether this may explain the
absence of a native 40-kDa CNTD1 isoform, we undertook an
extended sonication technique, but we were unable to identify
additional bands byWB (Figure 1D).We also consideredwhether
the CNTD1 full-length protein could migrate smaller than pre-
dicted by WB. However, when we expressed constructs encod-
ing the FLAG-HA-tagged full-length and short forms of CNTD1,
we detected both forms of the protein by WB using an anti-HA
antibody (Figure 1E). The CNTD1 short form migrates at the ex-
pected 30 kDa size. Thus, anti-HA antibodies can detect both
full-length and short-form CNTD1, but they detect only the latter
in mouse spermatocyte extracts, leading us to conclude that the
major CNTD1 variant found in mouse testis is the short-form 30-
kDa protein.
Comparative Analysis of CNTD1 Orthologs Reveals N-
Terminal Variability
Next, we examined the sequences of other CNTD1 orthologs.
Sequence alignment shows strong conservation of CNTD1
across a diverse set of species, with a few important caveats.
First, we identified an internal methionine that is absolutely
conserved throughout the entire family (Figure S3, blue). This
methionine corresponds to the alternative start codon thatnotes the conserved methionine of the short form in each homolog, with the
mouse, Iso1 and Iso2 are equivalent to the annotated full-length CNTD1 and
Ks expressed (prey), grown on control (-LEU-TRP) and selective plates (-ADE-
testis lysate. The stars indicate the non-specific bands.
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S3). Second, we observe greater variability in the N-terminal
portion of the protein upstream of this methionine (Figure 1F).
This manifests as splice variants within species that exhibit mul-
tiple annotated isoforms (Figure 1F). Splicing always preferen-
tially modifies the N terminus, leading to truncations that, at a
minimum, constitute the short form of the protein. The koala or-
tholog exemplifies this pattern of variability (Figure 1F). It is
important to note that one species, the American alligator, has
only a single short isoform described that begins at the alterna-
tive methionine start site (Figure S3, bottom row). These in silico
findings underscore the evolutionary conservation of the CNTD1
short form and suggest its broader biological importance.
The CNTD1 N Terminus Mediates Interactions with
Cyclin-Dependent Kinases
CNTD1 has predicted homology to cyclin proteins across 3 re-
gions: amino acids 57–88, 117–135, and 140–180 (Figure 1A).
Truncation of the N terminus in the CNTD1 short form removes
the first 85 amino acids, encompassing the majority of cyclin ho-
mology region 1 (Figure 1A). Using yeast two-hybrid analysis, we
investigated whether the CNTD1 short form would associate
with the CDKs that predominate in mouse spermatocytes,
CDKs 1, 2, 4, 5, and 6 (Adhikari et al., 2012; Ashley et al.,
2001; Barrie`re et al., 2007; Berthet et al., 2003; Session et al.,
2001). The full-length mouse CNTD1 interacts with CDK2 and
CDK4 in yeast two-hybrid assays (Figure 1G, top half). The
CNTD1 short form, however, fails to interact with any of the
tested CDKs (Figure 1G, bottom half). To determine whether
CDK2 andCDK4 interactions with CNTD1 exist in vivo, we immu-
noprecipitated CNTD1FH from mouse testis using the anti-HA
antibody and probed with antibodies against CDK2 and CDK4.
IP with anti-HA antibodies failed to enrich for either CDK2 or
CDK4 (Figure 1H), which is consistent with the conclusion that
the CNTD1 short form is the predominant isoform in mouse
and lacks the ability to interact with key prophase I CDKs.
CNTD1FH Forms Discrete Foci in Pachytene
Spermatocytes
We next undertook immunohistochemistry on testis sections
from Cntd1+/+ and Cntd1FH/FH littermates. In testis sections
from Cntd1FH/FH adults, we observed staining in primary sper-
matocytes using antibodies against the HA tag (Figures 2A, 2B,
S4A, and S4B). The localization of CNTD1 is restricted to pro-
phase I cells, but appears to shuttle between the nucleus and
cytoplasm in a stage-specific manner (Figures 2B and S4B).
Cytoplasmic localization is observed when staining intensity is
increased by prolonged exposure to 3,30-diaminobenzidine
(DAB) exposure (Figure S4B, square arrows), but staining re-
mains consistently heaviest in the nucleus (Figure S4B, arrows).
No HA signal was observed in testis sections from wild-type lit-
termates (Figures 2A and S4A).
We next used immunofluorescence staining on fixed testis
sections and chromosome spread preparations. Using the
same anti-HA antibody that we used in WB, which detected
only the CNTD1FH short orm, we observed discrete foci of
CNTD1FH at pachynema, distributed along the cores of the SC
in testis sections and spread meiotic spermatocytes (Figures4 Cell Reports 32, 107858, July 7, 20202C–2L). For chromosome spreads, we used colocalization with
the SC protein SYCP3 to assess the prophase I stage, providing
a temporal profile of CNTD1FH through prophase I. In leptonema,
we observed diffuse nuclear staining of CNTD1FH, which accu-
mulates along the SC in zygonema, with some foci observed
along the SC (Figures 2D and 2E). Throughout pachynema, the
diffuse nuclear staining of CNTD1FH is no longer observed, being
replaced by discrete foci along the SC at a frequency reminis-
cent of MutLg numbers (Figures 2F and J–L; Baker et al., 1996;
Lipkin et al., 2002). In early pachynema, localization of CNTD1FH
is observed in two distinct patterns: one population of cells has
yet to accumulate any CNTD1FH while a second population of
cells shows increasing focus frequency (Figure 2I). By mid-pa-
chynema, the focus frequency for CNTD1FH is more homoge-
neous, at 27 ± 2.7, and persisting at 26.5 ± 3.3 in late pachynema
(Figure 2I). By diplonema, the diffuse nuclear staining pattern re-
sumes, but clear foci of HA signal remain associated with the SC
(Figures 2G and 2H), and is lost by diakinesis.
From mid-pachynema onward, the number of HA-marked
CNTD1 foci is consistently higher than focus frequencies for
MLH1 and MLH3 (Baker et al., 1996; Lipkin et al., 2002; Figures
2I and S1F). Dual staining of CNTD1FH and MLH1 reveals the
frequent presence of CNTD1FH foci that do not co-localize with
MLH1 foci but not vice versa (Figure 2L). However, while we
observe colocalization of CNTD1FH and MLH1, given the spatial
distance over which fluorescent molecules excite, this only indi-
cates proximity but does not imply direct interaction.
In addition to the temporospatial pattern of CNTD1FH protein
signal, we observed 2 distinct intensity patterns for CNTD1FH
foci during pachynema: themajority of HA-stained foci are bright
and robust, while 1–5 foci per cell are of weaker intensity (Fig-
ure 2J). Increasing the imaging exposure time does not reveal
additional faint foci that are not included in our quantitation nor
do we observe any non-specific HA+ signal on chromosome
spreads from wild-type males (Figures S4C–S4F).
STA-PUT Protein Profiling
To define the temporal dynamics of CNTD1 appearance through
prophase I relative to other key meiotic and cell-cycle regulators,
an improved gravitational cell separation (STA-PUT) strategy
was devised to allow the recovery of all stages of prophase I in
a single procedure (Bellve´, 1993; Bellve´ et al., 1977; Romrell
et al., 1976). Meiotic chromosome spreads were prepared
from 46 fractions and scored based upon SC morphology and
presence of the phosphorylated histone variant gH2AFX (Gray
and Cohen, 2016). The purity of STA-PUT-enriched fractions
for each germ cell stage reached 67% leptonema, 45% zygo-
nema, 89% pachynema, 79% diplonema, and 98% sperm
across different fractions (Figure 3A). WB performed against pro-
teins from the STA-PUT cell fractions resulted in a dynamic pro-
file of protein levels using a battery of antibodies against meiosis
regulators (Figure 3A), all compared to the dynamic expression
of CNTD1 as detected by the HA tag. Detailed protein dynamics
are delineated below, describing the data in Figure 3A.
CNTD1FH Expression (HA)
The peak HA signal (for CNTD1FH) is observed within fractions
enriched for leptonema through pachynema, which is coincident
with the staining observed in spread testis spermatocytes. As
A B C
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Figure 2. CNTD1FH Localizes to Spermatocytes and Forms Discrete Foci at Pachytene
(A and B) Immunohistochemistry using anti-HA antibody on formalin-fixed testis sections of Cntd1+/+(A) and Cntd1FH/FH (B) mice, imaged at 2003. Bar, 300 mm.
(C) Immunofluorescence staining using anti-HA (green) and anti-SYCP3 (red) antibodies on formalin-fixed testis sections of Cntd1+/+ and Cntd1FH/FH mice,
imaged at 2003. Right-hand panels are enlargements of the dotted-outline box. Lower right-hand box shows the anti-HA staining (white) with cytoplasmic
staining and discreet foci.
(D–H) Immunofluorescence staining on spread meiotic spermatocyte preparations from Cntd1FH/FH mice using antibodies against the HA epitope (green) and
SYCP3 (red). Leptonema (D), zygonema (E), pachynema (F), diplonema (G), and diakinesis (H) staged spermatocytes defined by SYCP3 morphology.
(I) Quantification of HA foci (means ± SDs) in pachytene spermatocytes of Cntd1FH/FH mice.
(J) Enlarged image of dotted-outline box in (F). The closed arrowhead indicates strong intensity focus; the open arrowhead indicates low intensity focus.
(K) Structural illumination microscopy rendering of (J).
(L) Representative immunofluorescent staining of pachynema spermatocyte from Cntd1FH/FH testis using antibodies against MLH1 (red), HA (green), and SYCP3
(white). The right panel is the enlarged insert of the dotted-outline box. Colocalization of HA andMLH1 is identified by the yellow arrow; the green arrow indicates
HA-only foci.
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observed in our isolated purified cell populations.
Cell-Cycle Regulation
We observe the expression of CDK1 primarily in fractions en-
riched for leptotene through pachytene spermatocytes. A form
of CDK1 with increased electrophoretic mobility is observed in
pachynema. CDK2 has 2 characterized isoforms in the mouse;
a 34-kDa short form (CDK234) lacking 48 amino acids compared
with the longer 39-kDa (CDK239) isoform generated by alternatesplicing (Ellenrieder et al., 2001). The abundance and modifica-
tions of the two isoforms differs across STA-PUT-enriched
fractions.
The expression of CDK4 is observed in fractions enriched with
leptotene, zygotene, pachytene, and sperm cells. CDK4 staining
also shows an additional higher-molecular-weight-modified
band that appears from leptonema until pachynema, in line
with previously published localization patterns for CDK2 and
CDK4 (Ashley et al., 2001).Cell Reports 32, 107858, July 7, 2020 5
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Expression of the early RING domain crossover factor RNF212 is
observed coincident with the enrichment of leptotene cells and
spans fractions enriched for leptonema though early pachy-
nema. The appearance of the later-stage crossover protein
HEI10 occurs from zygonema onward and persists in pachy-
tene-enriched fractions. The expression of RNF212 and HEI10
fits the temporal progression of crossover sites gaining first,
RNF212, followed by HEI10 observed in spread meiotic sper-
matocytes (Qiao et al., 2014). In addition, Cntd1 mutants load
RNF212 but fail to load HEI10 (Holloway et al., 2014). The
appearance of the CNTD1FH signal relative to RNF212 and
HEI10 fits the temporal observations defined by chromosome
spreads, with RNF212 observed earliest, followed by CNTD1FH,
and then finally HEI10 (Qiao et al., 2014; Reynolds et al., 2013).
MLH3 protein accumulation is observed from leptotene-
through pachytene-enriched fractions. MLH3 antibody detects
two different bands of similar molecular weight, indicating
possible protein modification. Two isoforms of SYCP3 exist in
the mouse, with the longer form a consequence of N-terminal
extension (Alsheimer et al., 2010). Both isoforms of SYCP3 are
present in leptotene- through diplotene-enriched fractions. The
large form is predominant in the sperm- and leptotene-enriched
fractions and the short form is predominant in the diplotene-en-
riched fractions. Both forms of SYCP3 appear to have multiple
bands migrating around the similar molecular weight, indicating
protein modification. The central element SYCP1 forms between
synapsed chromosomes during zygotene and pachytene, and
appears in STA-PUT fractions enriched in zygotene through
pachytene spermatocytes.
DNA Repair Factors
Following DSB formation, phosphorylation of H2AFX on serine
139 (referred to as gH2AFX) occurs, leading to the recruitment
of repair factors and chromatin remodeling. On meiotic spread
chromosomes, gH2AFX is observed throughout leptotene as
DSBs occur and persists during DSB repair. During zygotene
and pachytene gH2AFX appears around the XY chromosomes,
forming the sex body. Detection of gH2AFX in the STA-PUT frac-
tions is consistent with these cytological observations. gH2AFX
appears as multiple bands throughout leptonema and becomes
a more discrete band in pachytene-enriched fractions. These
observations suggest that early, DSB-associated gH2AFX may
undergo different modifications than that of the XY-associated
protein.
Following DSB formation and early processing, RecA homo-
logs RAD51 and DMC1 undertake strand invasion to repair
from homologous DNA templates. Consistent with RAD51 stain-
ing on chromosome spreads, we observe RAD51 in leptotene
through pachytene-enriched fractions, with levels decreasing
as the fractions start to contain diplotene cells.Figure 3. STA-PUT Allows Isolation of Prophase I Stage-Specific Frac
(A) STA-PUT assay performed onCntd1FH/FH testis single-cell suspensions. Top: q
cells from spread preparations stained for SYCP3 and gH2AFX.WBs performed u
composite of four individual WBs performed and imaged under identical conditio
(B) Model depicting the 2 complexes identified as interacting partners with CNTD
between RFC-PCNA and MutLg is based upon in vitro experiments. The direct iMass Spectrometry (MS) of CNTD1FH-Enriched STA-PUT
Fractions Reveals Interactions with RFC and SCF
Complexes
Stage-matched prophase I cell fractions from Cntd1+/+ and
Cntd1FH/FH testes were used for IP against the HA epitope, fol-
lowed by MS to identify interacting proteins (green box in Fig-
ure S5). A total of 588 proteins (Table S1) were enriched in the
CNTD1FH sample compared with Cntd1+/+. A total of 181 pro-
teins were identified by R2 peptides. Given the localization
pattern and function in crossover formation, we did not identify
any proteins important for class I crossovers (MSH4, MSH5,
MLH1, MLH3, RNF212, HEI10, or CDK2), nor did we identify
any CDKs, consistent with the predominant expression of
Cntd1 short form inmouse testis. Instead,most CNTD1-interact-
ing proteins fall into Gene Ontology groups involved in cellular
and metabolic processes (Figure S6A). Of these, we prioritized
our continued analysis based on protein interactors that may
explain crossover designation, cell-cycle progression, and the
recent understanding of the role of post-translational modifica-
tions in driving these functions during meiosis (Ahuja et al.,
2017; Chen et al., 2015; Reynolds et al., 2013). Based on these
criteria, two specific complexes were of particular interest (Fig-
ure 3B). First, CNTD1FH interacts with components of the RFC
complex, which in somatic cells acts in the recruitment/activa-
tion of the DNA mismatch repair pathway (Bowen and Kolodner,
2017; Constantin et al., 2005; Kadyrov et al., 2006). Second,
CNTD1FH interacts with many proteins belonging to the ubiquity-
lation pathway (Figures 3B and S6B), including components of
the SKP1-Cullin-Fbox (SCF; reviewed in Lee and Diehl, 2014),
namely the E2 conjugating enzyme CDC34 (Figures 3B
and S6B).
RFC Complex
RFC is a pentameric complex, consisting of RFC1–5, which
loads proliferating cell nuclear antigen (PCNA) onto DNA during
DNA replication (Figure 3B; Majka and Burgers, 2004). RFC
and PCNA have been implicated in the activation of MutL endo-
nucleases (Bowen and Kolodner, 2017; Constantin et al., 2005;
Kadyrov et al., 2006; Smith et al., 2015). Our MS data revealed
CNTD1 interaction with RFC3 and RFC4 (Table S1), which was
confirmed by anti-HA-IP followed by WB using anti-RFC3 and
RFC4 antibodies (Figure 4A). WB analysis on whole-testis lysate
from Cntd1+/+ and Cntd1/mice demonstrated no difference in
the total protein levels of RFC3, RFC4, or PCNA (Figure 4B). In
STA-PUT fractions from Cntd1+/+ testes, we detected RFC3
and RFC4 protein in fractions enriched for leptonema through
pachynema cells, while PCNA persists until diplonema (Fig-
ure 4C). In STA-PUT fractions from Cntd1/ testes, RFC3 and
RFC4 protein levels were decreased in lanes representingmostly
pachytene cells, compared to similar lanes in WBs from STA-
PUT-sorted Cntd1+/+ fractions (Figure 5A).tions Revealing Dynamic Protein Expression
uantification of STA-PUT cell fraction composition based on aminimum of 200
sing the described antibodies against each STA-PUT fraction. EachWB row is a
ns.
1 in our MS analysis: RFC (left) and SCF (right). The hypothesized interaction
nteractions with CNTD1 are depicted by black arrows.
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somes using antibodies against RFC3 and RFC4 revealed faint
nuclear staining and focus formation along regions of the synap-
tonemal complex in pachynema. In pachytene spermatocytes
from Cntd1/ males, the overall nuclear staining of RFC3 and
RFC4 was reduced, as was the specific number of RFC3/4 foci
along autosomal synaptonemal complexes compared with that
observed in Cntd1FH/FH cells (Figures 5B–5E). By contrast,
PCNA immunofluorescence staining in pachytene spermato-
cytes from Cntd1FH/FH males revealed diffuse nuclear staining
in addition to discrete foci of PCNA along chromosome cores,
some reminiscent of the patterning observed when staining for
class I crossover proteins (Figure 5F). By contrast, PCNA stain-
ing in pachytene spermatocytes from Cntd1/ males was
more intense across the entire nucleus, including the signal
observed along the synaptonemal complex (Figure 5G).
Immunolocalization of RFC4 protein in testis sections revealed
a robust RFC4 signal within the nuclei of spermatogonia and pri-
mary spermatocytes in wild-type testes (Figure 5H), with a
steadily increasing signal for RFC4 as prophase I progresses
(Figure 5B). In testis sections from Cntd1/ males, we observe
persistent, stronger staining of RFC4 in spermatogonia
compared with Cntd1FH/FH males (Figure 5I), but decreased
staining in the primary spermatocytes at all stages of prophase
I relative to that observed in Cntd1+/+ spermatocytes (Figures
5H and 5I, right-hand gray panels, and S7).
PCNA staining of Cntd1+/+ testis revealed nuclear staining in
occasional spermatogonia and all of the primary spermatocytes
(Figure 5J). Similar staining is observed in primary spermato-
cytes in Cntd1/ males, with an increased intensity of PCNA
signal due to the higher proportion of spermatocytes compared
to that observed in adult Cntd1+/+ testis (Figures 5K and S7).
However, the staining intensity in individual sub-stages of pro-
phase I appears persistently more robust in spermatocytes
from Cntd1/ males than in wild type (Figures 5J and 5K,
right-hand gray panels, S7). These results demonstrate the
robust localization of RFC and PCNA in late-stage primary sper-
matocytes, distinct from their expected staining in cells undergo-
ing DNA replication (e.g., proliferating spermatogonia). In this re-
gard, our data suggest that RFC and PCNA may play a role in
DSB repair during meiosis that is analogous to their role in
DNA repair in somatic cells in regard to MutL complexes (Majka
and Burgers, 2004).
CDC34 E2 Conjugating Enzyme
The SCF complex is the most widely characterized of the super-
family of Cullin/RING ubiquitin ligases (CRLs) (Sarikas et al.,
2011). The SCF core complex works together with E1 (activating)
and E2 (conjugating) enzymes to define ubiquitylation substratesFigure 4. CNTD1 Mutation Leads to a Decrease in CDC34 Levels Com
(A and B) WB using antibodies against CNTD1FH-interacting proteins from immu
from testis lysate (B) of Cntd1FH/FH, Cntd1FH/, and Cntd1/ mice.
(C) STA-PUT assay performed on Cntd1FH/FH testis single-cell suspensions sho
relative to prophase I stage. Top panel: quantification of STA-PUT cell fraction co
with SYCP3 and ggH2AFX antibodies. WBs were performed using the described
(D) WB using antibodies against CDC34 and GAPDH on lysate from whole testis
(E) WB against predicted downstream CDC34 targets and GAPDH control.
(F) WEE1 inhibitory phosphorylation on CDK1 and CDK2.(Figure 3B; Reitsma et al., 2017). Our MS data revealed that
CNTD1 interacts with 22 components of the ubiquitylation/de-
ubiquitylation family (Figure S6B; Table S1), including the E2
conjugating enzyme CDC34.
The distribution of CDC34 protein across STA-PUT fractions
from Cntd1+/+ males primarily revealed protein in fractions en-
riched with round spermatids, sperm, leptotene, and zygotene
cell types (Figure 4C, fractions 32–42). IP-WB confirmed the in-
teractions between CNTD1FH and CDC34 (Figure 4A), while
WB from whole-testis lysates revealed that CDC34 levels in
Cntd1/ mutants were drastically decreased compared with
those of Cntd1FH/FH animals (Figure 4B). Because of this interac-
tion, we asked whether CDC34 levels were similarly altered in
crossover mutants for genes acting downstream of CNTD1.
CDC34 protein levels were reduced inMlh1/ mice to a similar
extent as those observed in Cntd1/ mice (Figure 4D). The WB
profile of CDC34 protein across STA-PUT fractions from
Cntd1/ males, where prophase I cells are present but sperm
is absent, showed a similar drastic reduction in CDC34 protein
(Figure 5K). Therefore, the lack of CDC34 protein is a conse-
quence of a failure to form a competent crossover complex
and subsequent lack of later-stage cells.
Immunofluorescence staining on testis sections revealed the
most prominent CDC34 signal in round and elongating sperma-
tids of Cntd1FH/FH males. Cntd1/ males, lacking these post-
meiotic cell types, failed to show significant CDC34 staining
(Figures 6A and 6B).
Targets of CDC34 Are Drivers of Cell-Cycle Progression
and Crossover Regulation during Prophase I
CDC34 targets the WEE1 kinase for degradation in mitosis
(Michael and Newport, 1998). WEE1 functions as a mitotic inhib-
itor (Michael and Newport, 1998; Morgan, 1995; Sadowski et al.,
2007; Sandoval et al., 2015; Smith et al., 2007), specifically inhib-
iting the CDK1 component of maturation-promoting factor (MPF)
to prevent premature metaphase I entry (Dunphy, 1994; Morgan,
1995; Nurse, 1990; Figure 4F). WEE1 degradation thus allows
MPF activation to facilitate cell-cycle progression. Accordingly,
WEE1 staining in fixed testis sections revealed strong cyto-
plasmic and diffuse faint nuclear localization in prophase I sper-
matocytes from Cntd1FH/FH males, with the nuclear localization
disappearing by diplonema (Figure 6C).
Given the lack of post-spermatocyte cells in Cntd1/ males
and the decrease in CDC34 protein in these animals, we hypoth-
esized that the regulation of WEE1 was defective in Cntd1/
males. WEE1 was decreased in protein extracts from testes of
Cntd1/ males compared with Cntd1FH/FH males, whereas
CDK1 and CDK2 protein levels were not significantly alteredpared to Wild Type
noprecipitated material using anti-HA antibody from Cntd1FH/FH mice (A) and
wing expression of CNTD1FH interacting factors and downstream interactors
mposition based on a minimum of 200 cells from spread preparations stained
antibodies against each STA-PUT fraction.
, Wild-type, Cntd1/, and Mlh1/ mice.
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observed throughout prophase I and remains elevated at diplo-
nema in spermatocytes of Cntd1/ males rather than diminish-
ing as in wild-type testes (Figure 6D).
WEE1 inhibits CDK1 and CDK2 activity by phosphorylation on
tyrosine 15 (Gould and Nurse, 1989; Gu et al., 1992; Krek et al.,
1992; Morla et al., 1989), but phospho-specific antibodies
against tyrosine 15 of CDK1 and CDK2 did not reveal any signif-
icant change in whole-testis lysate from Cntd1/ males
compared to Cntd1FH/FH animals (Figure 4E). Therefore, to
assess prophase I stage-specific changes in WEE1 phosphory-
lation, we stained testis sections from Cntd1FH/FH and Cntd1/
males using a pan-CDK phospho-tyrosine 15 antibody (Figures
6E and 6F). We observed strong cytoplasmic staining of early
prophase I Cntd1FH/FH spermatocytes that is lost by diplonema
(Figure 6E). By contrast, we observed the retention of the cyto-
plasmic pan-CDK phospho-tyrosine 15 signal throughout pro-
phase I in testis sections of Cntd1/ males (Figure 6F).
CDK1 and CDK2 staining in Cntd1FH/FH cells appear to be dy-
namic between the cytoplasm and nucleus throughout prophase
I (Figures 6G and 6I). In early prophase I, CDK1 and CDK2 are
distributed between both cellular compartments, but by diplo-
nema show strong nuclear staining. By contrast, staining of
CDK1 and CDK2 in testis sections from Cntd1/ males reveals
much less-intense nuclear signal with only faint cytoplasmic
staining and no localization in the nucleus by diplonema (Figures
6H and 6J). These data suggest that SCF is misregulated in
Cntd1/ males relative to Cntd1FH/FH, leading to decreased
CDC34 levels. This in turn results in increasedWEE1+ cells within
the seminiferous epithelium of Cntd1/ males coupled with a
decrease in CDK1 and CDK2 staining in the nucleus of late pro-
phase I cells and a persistence of inhibited CDKs in the cyto-
plasm (Figures 6G–6L). We postulate that the insufficient degra-
dation of WEE1 arising from the loss of CNTD1 and CDC34
directly contributes to the failure of cell-cycle progression.
In Vitro Inhibition of WEE1 Facilitates Progression into
Metaphase I and Is a Prerequisite for Spindle Assembly
Checkpoint (SAC) Activation
Following prophase I, cells progress to metaphase I, the stage at
which the SAC monitors correct microtubule attachment before
entry into anaphase I. We postulated that spermatocytes from
Cntd1/ males fail to progress past prophase I to the meta-
phase-to-anaphase transition, and thus do not activate the
SAC. To test this, we cultured prophase I cells from Cntd1+/+Figure 5. CNTD1 Mutation Causes a Decrease in Nuclear RFC4 Signal
(A) STA-PUT assay performed on Cntd1/ testis single-cell suspension from 12
prophase I stage. Top panel: quantification of STA-PUT cell fraction composition b
and gH2AFX antibodies. WBs were performed using the described antibodies ag
WBs performed and imaged under identical conditions.
(B–G) Immunofluorescence staining of pachynema staged spread meiotic sperm
RFC3 (B and C), RFC4 (D and E), and PCNA (F and G) antibodies.
(H and I) Immunofluorescence staining using antibodies against RFC4 (green) and
mice, imaged at 2003. The white bars indicate the prophase I cells. The arrowhe
hand panels show representative images of the prophase I stages from enlarged
(J and K) Immunofluorescence staining using antibodies against PCNA (green) an
(K) mice, imaged at 2003. The white bars indicate the prophase I cells. The arro
right-hand panels show representative images of the prophase I stages from enland Cntd1/ males for short periods of time in the presence
of adavosertib (MK-1775) (0.25–10 mg/mL), aWEE1 kinase inhib-
itor, and/or nocodazole (1–80 mg/mL), a microtubule polymeriza-
tion inhibitor. As a readout for drug activity andmetaphase entry/
progression, we used WB analysis to monitor the levels of the
anaphase I inhibitor MAD2L2 and inhibitory phospho-tyrosine
15 on CDK1 and CDK2 for SAC and WEE1 activity, respectively.
Cells from Cntd1/ males showed reduced CDK1 and CDK2
inhibitory phosphorylation when treated with adavosertib alone,
while cells treated with nocodazole alone failed to show any in-
crease in the levels of MAD2L2 (Figures 7A and 7B). Only when
both drugs were applied to these cells was the inhibition of
anaphase I progression observed, reflected by an increase in
MAD2L2 protein levels (Figures 7A and 7B). Accordingly,
whole-testis lysates from Cntd1/ males showed a decrease
in MAD2L2 protein levels compared to those of wild-type males
(Figure 7C), which is indicative of a reduced number of cells
completing prophase I.
To our surprise, cultured spermatocytes from wild-type males
showed a similar requirement for both adavosertib and nocoda-
zole treatment to elicit a MAD2L2 response (Figures 7A and 7B).
These data indicate that the inhibition of WEE1 is required for
progression into metaphase and that the treatment of wild-
type spermatocytes with adavosertib results in the massive
and rapid induction of metaphase I entry, thus permitting pro-
gression through to anaphase I. Without adavosertib, too few
cells naturally progress into metaphase to be detected by
MAD2L2 protein induction (Figure 7D).
DISCUSSION
Crossovers are essential for the accurate segregation of homol-
ogous chromosomes during meiosis I. The present article shows
that CNTD1FH foci are found in a similar distribution and fre-
quency to those of MutLg, often co-localizing with this complex.
Approximately 1–5 MLH1-independent foci exist per cell, remi-
niscent of the number of crossovers expected to form through
MutLg-independent mechanisms (Holloway et al., 2008). Thus,
we propose that CNTD1 localizes to all nascent crossover sites,
not only those destined to form MutLg-dependent crossovers.
We do not find any discrete CNTD1FH signal before pachynema,
suggesting that CNTD1 accumulates at a timewhen class I and II
crossovers are becoming designated.
Using an epitope-tagged allele of Cntd1, we demonstrate that
a short form of CNTD1, arising from the translation of an internaland Persistent Increased Nuclear Signal of PCNA in Prophase I Cells
adult mice showing expression of RFC3, RFC4, PCNA, and CDC34 relative to
ased on aminimum of 200 cells from spread preparations stained with SYCP3
ainst each STA-PUT fraction. Each WB row is an amalgamation of 4 individual
atocytes from Cntd1FH/FH (B, D, and F) and Cntd1/ (C, E, and G) mice using
SYCP3 (red) on formalin-fixed testis sections ofCntd1FH/FH (H) andCntd1/ (I)
ads indicate spermatogonia and the arrows indicate spermatocytes. The right-
sections of (H) and (I), respectively, staged by SYCP3 morphology.
d SYCP3 (red) on formalin-fixed testis sections of Cntd1FH/FH (J) and Cntd1/
wheads indicate spermatogonia and the arrows indicate spermatocytes. The
arged sections of (J) and (K), respectively, staged by SYCP3 morphology.
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Figure 6. CDC34 Levels Are Decreased and Downstream Targets Are Mislocalized in CNTD1 Mutants
(A andB) Immunofluorescence using antibodies against CDC34 (green) and SYCP3 (red) on formalin-fixed testis sections ofCntd1FH/FH (A) andCntd1/ (B) mice,
imaged at 2003. The white bars indicate the prophase I cells. The right-hand gray panels show representative images of the prophase I stages from enlarged
sections of (A) and (B), respectively, staged by the morphology of the synaptonemal complex from SYCP3 staining.
(legend continued on next page)
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lines of evidence support this conclusion: (1) migration of
CNTD1-FH on WB and the corroborating localization of the
tagged protein on meiotic chromosome cores in prophase I (Fig-
ures 1B–1E and 2C–2L) and (2) multiple anti-HA antibodies can
detect both full-length and short forms of the protein when ex-
pressed in yeast, and they migrate relative to their predicted
size, indicating that if a full-length protein did exist in spermato-
cytes, we would be able to detect it. The CNTD1 short-form pro-
tein lacks the first cyclin homology domain and is incapable of
associating directly with any known CDKs. Our MS and IP-WB
data, however, show that the CNTD1 short form can interact
with the regulators of CDK activity, thereby providing an indirect
mechanism by which progression through the cell cycle can be
modulated following appropriate crossing over. We cannot
exclude the possibility that the CNTD1 short form maintains
some cyclin-like functions since it still contains two cyclin homol-
ogy domains with predicted structural similarity to cyclin A. In
fact, these cyclin domains may be critical for protein transloca-
tion between the cytoplasm and the nucleus at defined stages
during prophase I, as observed in CNTD1 short-form staining
(Figure S4) and as has previously been shown for cyclin
domain-containing proteins (Kong et al., 2000). We also cannot
rule out that the full-length version of CNTD1 exists in low, unde-
tectable levels or that it is more predominant in females. In testis
frommale mice, however, we find only a single bandmigrating at
a size that corresponds with the epitope-tagged short form of
CNTD1, while the same antibodies used on chromosome
spread preparations localize exclusively to sites that correspond
with nascent crossovers and mostly correspond to MutLg
localization.
Although the internal methionine start site used to generate the
short-formmouse CNTD1 is absolutely conserved, the CNTD1 N
terminus shows variability across and within species, with many
organisms showing multiple isoforms in this region. These differ-
ences may reflect divergent CNTD1 functions, with some homo-
logs retaining the ability to maintain direct CDK interactions and
act as canonical cyclins, while others must exert their effects
indirectly.
Our MS identified interactions between CNTD1 and compo-
nents of the RFC complex. While RFC and PCNA are required
for the activity of human and yeast MutLa in vitro (Constantin
et al., 2005; Kadyrov et al., 2006; Smith et al., 2015), yeast MutLg
displays activity independent of these proteins (Manhart and
Alani, 2016). However, more recent studies (currently in preprint
form) have demonstrated that RFC and PCNA activate mamma-
lian MutLg (Cannavo et al., 2020; Kulkarni et al., 2020). While no
information exists to describe the interaction between RFC and
PCNA complexes in mammalian germ cells in vivo, it is likely,
given the observations frommitotic, biochemical, and in vitro as-
says, that these complexes interact, potentially in a DNA sub-
strate-specific manner. Moreover, our previous studies have
demonstrated the importance of PCNA in meiotic prophase I in(C–J) Immunofluorescence using antibodies against WEE1 (C and D) and its targe
formalin-fixed testis sections of Cntd1FH/FH (left column panels C, E, G, and I) and
indicate the prophase I cells; the arrow highlights the spermatocytes. The right-
enlarged sections, staged by SYCP3 morphology.the mouse (Roa et al., 2008). In the present work, we observe
a decreased cellular signal of RFC4 but a stronger nuclear stain-
ing pattern of PCNA throughout prophase I in testis sections
from Cntd1 mutants. On meiotic spread preparations, PCNA
localization along the SC increases in the absence CNTD1, coin-
cident with the decreased localization of RFC3/4. Previous char-
acterizations ofCntd1GT/GTmalemice revealed normal prophase
I progression before crossover formation and normal DSB for-
mation and repair kinetics with no persistent DSBs observed
(Holloway et al., 2014). The progression of spermatocytes
through to pachynema of prophase I in testis from Cntd1/ an-
imals (Figures 5 and 6) indicates that the kinetics of early DSB in-
duction and repair are largely normal. The persistent strong nu-
clear and SC staining of PCNA that we observe within Cntd1
null mutants is therefore not a consequence of the failure to un-
dergo appropriate early DNA repair events. This is further sup-
ported by diakinesis spreads that show decreased bivalent for-
mation in Cntd1/ animals, but not fragmented chromosomes
forming as a result of unrepaired DSBs. Based on these observa-
tions, we propose that the persistent PCNA signal (and not RFC)
is not related to ongoing DNA synthesis associated with meiotic
recombination in Cntd1/ animals, but is instead a prelude to
active crossover formation, with CNTD1-RFC-PCNA being
required to localize proteins at the correct location and time to
achieve class I crossovers. New observations from the Cejka
and Hunter labs support our observations and our conclusion
that PCNA-RFC interactions facilitate MutLg-stimulated cross-
over formation (Cannavo et al., 2020; Kulkarni et al., 2020).
CNTD1 interacts with several components of the SCF ubiqui-
tylation complex (Figure S6B), including the E2 conjugating
enzyme CDC34. Although we have not identified the partner
E3 ubiquitin ligase(s) that functions with CDC34, previous find-
ings in Xenopus identified the cell-cycle kinase WEE1 as a spe-
cific target of CDC34 (Michael and Newport, 1998). WEE1 exerts
inhibitory effects through the phosphorylation of CDK1 and
CDK2, and its removal enables mitotic cell-cycle progression
(Gu et al., 1992; Morgan, 1995; Welburn et al., 2007). We find a
similar mechanism functioning during meiotic prophase I in the
male mouse. In this context, WEE1 phosphorylation of CDK1
maintains MPF in an inactive state and prevents cyclin B-
CDK1-induced progression to metaphase. Cntd1 null mutants
show a decreased CDC34 signal, a retention of WEE1 in the nu-
cleus throughout prophase I, continued inhibitory phosphoryla-
tion of its targets within the cytoplasm, and a consequent failure
to localize CDK1 and CDK2 within the nucleus of late-stage pro-
phase I cells. However, the total WEE1 signal from the testis of
Cntd1/ animals showed a decrease compared with that of
Cntd1FH/FH animals.While we cannot fully explain this difference,
the lack of post-meiosis I cells in the Cntd1/ animals or the dif-
ference in total protein found in the cytoplasmic versus nuclear
compartments may account for the difference in total protein.
These observations strongly argue that CNTD1 acts upstream
of WEE1 through association with CDC34 and relieves thets, including pan-tyrosine15 (E and F), CDK1 (G and H), and CDK2 (I and J), on
Cntd1/ (right column panels D, F, H, and J), imaged at 2003. The white bars
hand gray panels show representative images of the prophase I stages from
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the timing of cell-cycle progression with proper crossover
formation.
To clarify the connection between CNTD1 and cell-cycle
progression, we devised a strategy to investigate how
CNTD1-mediated WEE1 inhibition could perturb the comple-
tion of prophase I. To test this in an in vitro short-term culture
system, we used the small-molecule WEE1 inhibitor adavoser-
tib in conjunction with the metaphase-to-anaphase inhibitor
nocodazole. Only with combined treatment using both drugs
were we able to observe the inhibition of metaphase I progres-
sion, indicative of an induced SAC, and such a result was
observed in spermatocytes from both wild-type and Cntd1
mutant males. These results demonstrate a requirement for
WEE1 degradation/inhibition to allow metaphase I entry and
thus to facilitate progression to the metaphase-anaphase
boundary (Figure 7D).
Collectively, our work defines two modes of action for
CNTD1 in meiosis: simultaneously stimulating crossover forma-
tion through association with RFC while concomitantly regu-
lating cell-cycle progression through interactions with CDC34
and subsequent ubiquitylation of WEE1 (Figure 7E). While
these activities are distinct, the localization of both CNTD1FH
and CDK2 at crossover sites, together with the fact that
CDK1 and CDK2 are both downstream targets of the SCF
complex, support the integrated regulation by CNTD1 of the
processes governing crossover formation and cell-cycle pro-
gression. Despite the persistent colocalization of CNTD1 and
CDK2 in recombination foci throughout the 7 days of mouse
pachynema, we cannot find any evidence of a physical interac-
tion between these two proteins in vivo. Instead, our findings
show that CNTD1 interacts with key players of crossover for-
mation and cell-cycle progression and that the loss of
CNTD1 leads to the misregulated localization of these factors.
We propose that CNTD1 functions to coordinate these pro-
cesses, indirectly affecting the activity of cell-cycle regulators
and implicating CNTD1 as a stop-go regulator mechanism,
monitoring crossover formation akin to a crossover-specific
checkpoint, which may also be activated by the cellular ma-
chinery downstream of CNTD1. CNTD1 interactions with RFC
in the context of the RAD17-RFC complex, an established
cell-cycle checkpoint mediator (Ohashi and Tsurimoto, 2017),
could provide additional crosstalk and control of these path-
ways (Figure 7E). While our findings have immediate implica-
tions for the timing and control of prophase I in the male
mouse, the dual nature of CNTD1 pathway interactions that
we have uncovered here and the potential of variable splicingFigure 7. In Vitro Short-Term Cultures Reveal a WEE1-Dependent Mei
(A)WB using antibodies againstWEE1 inhibitory phosphorylation targets CDK1-pY
cultured spermatocytes from Cntd1+/+ and Cntd1/ males with adavosertib, noc
(see Method Details).
(B) Analysis of protein signal from WB in (A) divided by GAPDH signal, relative to
(C) WB against MAD2L2 in whole testis lysates from Cntd1+/+ and Cntd1/ mal
(D) Inhibitory phosphorylation of CDK1 and CDK2 by WEE1, which itself is degrad
inhibition allows the activation of the MPF and progression into metaphase I. Th
crotubules and prevents the progression from metaphase I to anaphase I. Noco
(E) Model of CNTD1 function based on results presented in the present article.at the N terminus implicate CNTD1 as a regulatory nexus
throughout the animal kingdom.
Limitations of Study
The present article describing our elucidation of CNTD1 func-
tion was submitted for consideration in November 2019. Re-
viewers’ comments were received in February 2020, but we
were unable to fully address some of the points due to the
outbreak of coronavirus disease 2019 (COVID-19). While we
addressed the vast majority of points raised by the reviewers,
due to our inability to undertake additional experiments, we
have identified three limitations to our study. First, while we
have identified a short-form CNTD1 protein by WB, a reviewer
suggested a modified protein extraction technique to identify
whether an additional CNTD1 form could be observed. Second,
while we have shown interactions of CNTD1 with components
of the RFC complex and CDC34 by unbiased (MS) and biased
(IP-WB) methods, because of the importance of these interac-
tions, a reviewer asked for further confirmation of interaction by
other biochemical methods. Finally, reviewers asked us to build
on data in Figure 4 and data within Figure 7 with the inclusion of
drug treatment on an additional meiotic crossover mutant
(Mlh1/). Such studies will be pursued once our laboratories
reopen.
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CDC34 Proteintech Cat# 10964-2-AP; RRID: AB_2077925
CDK1 Millipore Cat# MAB8878; RRID: AB_2074771
CDK1-pY15 Abcam Cat# ab47594; RRID: AB_869073
CDK2 Santa Cruz Cat# sc-163; RRID: AB_631215
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GAPDH Invitrogen Cat# MA5-15738-HRP; RRID: AB_2537659
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MLH3 Custom made (Holloway et al., 2008) N/A
MAD2L2 Proteintech Cat# 12683-1-AP; RRID: AB_2139530
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SYCP1 Abcam aCat# b15090; RRID: AB_301636
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gH2AFX Millipore Cat# 05-636; RRID: AB_309864
Chemicals, Peptides, and Recombinant Proteins
Adavosertib MedChemExpress Cat# HY-10993
Nocodazole Sigma Aldrich Cat# SML1665-1ML
Experimental Models: Organisms/Strains
M. musculus C57BL/6J The Jackson Laboratory 000664
S. cerevisiae Y2H Gold Takarabio 630498
Oligonucleotides
CNTD1-FH crRNA: ccgcuuccucuaacacguga This Paper N/A
CNTD1-FH HDR Donor: cctgggccacag
cagcctgttccccacaaggcagccagagctctga
ggactgctgccgctgccgcttcctctaacacg
GACTACAAAGACGATGACGACAAGcttT
ACCCATACGATGTTCCAGATTACGCTt
gagggtggctgacccgcactgccttgtcactgg
acctctttccttgtttacttttatactcaggg
This Paper N/A
CNTD1-FH Sequencing Primer, Forward:
gcgcacgagtgtttgtgcact
This Paper N/A
CNTD1-FH Sequencing Primer, Reverse:
ccagtgacaaggcagtgcgggtcagcc
This Paper N/A
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CNTD1 Mutant crRNA: UAGUGACUUUCA
GUUCGGAG
This Paper N/A
CNTD1 Wildtype and Mutant Primer,
Forward: CCAAGGTGTGGCAGAAGATTC
This Paper N/A
CNTD1 Wildtype Primer, Reverse:
ctgtcaattccaggccagcc
This Paper N/A
CNTD1 Mutant Primer, Reverse:
AGCCCTTGGAGGAGCCC
This Paper N/A
Recombinant DNA
pGADT7 AD Clontech 630442
pGBKT7 DNA-BD Clontech 630443
pX330 Addgene 42230
Software and Algorithms
Adobe Creative Cloud Adobe https://www.adobe.com/uk/creativecloud.html
Fiji-ImageJ (Schneider et al., 2012) https://imagej.nih.gov/ij/
GraphPad Prism 6.0 GraphPad https://www.graphpad.com
Image Lab 6.0 Bio-Rad https://www.bio-rad.com/en-us/product/
image-lab-software?ID=KRE6P5E8Z
Zen 2.0 Zeiss https://www.zeiss.com/microscopy/int/
products/microscope-software/zen.html
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Lead Contact
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Paula
Cohen (paula.cohen@cornell.edu)
Materials Availability
Plasmids andmouse lines generatedwithin this study are available upon request from the LeadContact, Paula Cohen (paula.cohen@
cornell.edu)
Data and Code availability
This study did not generate any code. Mass spectrometry dataset generated in this study is found within Table S1.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mouse strains
All mouse alleles were maintained on a C57BL6/J background, with at least six successive backcrosses. CRISPR/Cas9 genome edi-
ted mice were created initially on a FVB x C57B6 background before undergoing backcrossing. In all cases, analysis was performed
on adult male mice between the ages of 10 and 14 weeks. All mice were maintained under strictly defined conditions of constant
temperature and light:day cycles, with food and water ad libitum. Animal handling and procedures were performed following
approval by the Cornell Institutional Animal Care and Use Committee, under protocol 2004-0063.
Transgenic mice generation
Cntd1-FLAG-HA: CRISPR/Cas9 was used to insert the FLAG-HA epitope at the C terminus of the Cntd1 locus. The RNA guide was
generated by cloning the Cntd1 specific sequence (GCCGCTTCCTCTAACACGTGA) in between the BbsI restriction sites of pX330,
courtesy of Feng Zhang (Addgene #42230). Once integrated, the region including the gRNA scaffold was PCR amplified to include the
T7 promoter. The PCR fragment was used to in an in vitro transcription reaction using the Ambion MEGAshortscript T7 Transcription
Kit (AM1354). Single-stranded DNA homology donor containing 78 nucleotides of homology upstream of the guide sequence, FLAG
and HA epitopes separated by a leucine (generating a HindIII restriction site) and 66 nucleotides of homology downstream of the
Cntd1 stop codon was generated by IDT. gRNA, DNA donor and Cas9 mRNA was injected into 146 C57BL/6J x FVB F1 zygotes.
119 two-cell embryos were surgically implanted in 5 female recipients leading to the birth of 46 founder mice. PCR screening
identified 7 founders with DNA integrated at the locus, 3 of which were the correct size. Sequencing revealed one founder mousee2 Cell Reports 32, 107858, July 7, 2020
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ing used for experiments described.
Cntd1 null allele
CRISPR/Cas9 was used to generate a DNA double-strand break at theCntd1 locus and founder mice were screened for non-homol-
ogous end joining events generating a frameshift mutation. The gRNA was generated using long PCR primers incorporating the T7
promoter, targeting sequence and Cas9 scaffold followed by PCR and in vitro transcription (see above). Founders were screened for
mutations by PCR of the Cntd1 locus followed by sequencing. One founder carried an incorporation of 324 nucleotides of chromo-
some 12 at the targeted locus leading to disruption of the Cntd1open reading frame.
Yeast strain
Y2H Gold yeast strain (detailed in Key Resources Table) was used for yeast two-hybrid experiments and protein expression.
METHOD DETAILS
Plasmid construction
Yeast two-hybrid
Testis cDNA was generated from Trizol extracted RNA using the Invitrogen SuperScript III First-Strand Synthesis System. CDKs 1,
2, 4, 5 and 6 were PCR amplified to includeNdeI and BamHI restriction sites upstream and downstream respectively. The CDKswere
cloned into Clontech yeast two-hybrid prey vector, pGADT7, using the Roche Rapid DNA Dephos & Ligation Kit. Annotated full-
length CNTD1 and CNTD1 short-form sequences were PCR amplified to include NcoI and BamHI restriction sites upstream and
downstream respectively. The CNTD1 sequences were cloned into the Clontech yeast two-hybrid bait vector pGBKT7.
CNTD1 expression constructs
The yeast CEN/ARS region from pRS414 was PCR amplified, introducing restriction sites SpeI upstream and EcoRV downstream.
This fragment was cloned into pFA6a-HphMX. The promoter of ADH1 from pGADT7 along with FLAG-HA epitope taggedCNTD1 full-
length and short-forms from mouse testis cDNA was PCR amplified and cloned into the previously constructed vector using Gibson
Assembly.
Cntd1 Orthology Sequence Alignment
Sequence alignments carried out using Clustal Omega. NCBI database IDs for annotated isoform sequences are as follows: Mus
musculus (mouse), Iso1: NP_080838.1, Iso2: EDL01034.1; Homo sapiens (human), Iso1: NP_775749.2, IsoX2: XP_006721753.1,
IsoX1: XP_005257100.2, Iso2: NP_001317151.1; Pan troglodytes (chimpanzee), IsoX1: XP_009430406, IsoX3, XP_016787256.1,
IsoX2: XP_016787255.1, IsoX4: XP_024206054.1; Phascolarctos cinereus (koala), IsoX1: XP_020828270.1, IsoX2:
XP_020828271.1, IsoX3: XP_020828272.1, IsoX4: XP_020828273.1; Canis familiaris (dog), IsoX2: XP_022278673.1, IsoX4:
XP_022278675.1; Castor canadensis (American beaver), IsoX1: XP_020020731.1, IsoX2: XP_020020732.1.
Yeast two-hybrid assay
The yeast two-hybrid assay was performed as described by the manufacturer, Clontech. Briefly, combinations of bait and prey plas-
mids were transformed into the yeast two-hybrid reporter strain Y2HGold and plated onto –LEU –TRP selection plates. Positive
colonies were re-streaked and tested for plasmids using PCR. Single colonies were inoculated into –LEU –TRP media and grown
overnight. Colonies were normalized to an OD600 or 1.0 and four, 10-fold dilutions made. 10ml drops were placed on selection plates
and quadruple dropout plates, which were incubated at 30C for 3 days.
Chromosome analysis and immunofluorescence
Chromosome spreads were made as previously described in Holloway et al. (2014). Briefly, decapsulated testis tubules were incu-
bated in hypertonic elution buffer (30 mM Tris pH7.2, 50mM sucrose, 17mM trisodium dehydrate, 5 mMEDTA, 0.5 mMDTT, 0.1 mM
PMSF, pH8.2-8.4) for one hour. Small sections of testis tubule were dissected in 100mM sucrose and spread onto 1% Paraformal-
dehyde, 0.15% Triton X coated slides and incubated in a humid chamber for 2.5hrs at room temperature. Slides were dried for 30mi-
nutes, washed in 1x PBS, 0.4% Photoflo (Kodak 1464510) and either stored at80C or stained. For staining, slides were washed in
1xPBS, 0.4% Photoflo for 10 minutes, followed by a 10 minute wash in 1x PBS, 0.1% Triton X and finally a 10 minute wash in 10%
antibody dilution buffer (3% BSA, 10%Goat Serum, 0.0125% Triton X, 1 x PBS) 1x PBS. Antibodies used in this study are described
in Table S1. Primary antibodies were diluted in 100%antibody dilution buffer, placed as a bubble on parafilmwithin a humid chamber,
and the surface of the slide spread on the parafilm allowing the antibody to spread across the surface of the slide. Slides were incu-
bated at 4C overnight. Slides were washed in 1xPBS, 0.4% Photoflo for 10 minutes, followed by a 10 minute wash in 1x PBS, 0.1%
Triton X and finally a 10 minute wash in 10% antibody dilution buffer. Secondary antibodies were diluted as the primary antibodies
and spread in a similar fashion. Slides were incubated at 37C for one hour. Slides were washed in 1xPBS, 0.4% Photoflo for
10 minutes, three times. Finally slides were left to dry, mounted using DAPI/antifade mix and either imaged or stored at 4C for later
imaging. Slides were imaged on a Zeiss Axiophot with Zen 2.0 software.Cell Reports 32, 107858, July 7, 2020 e3
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Adult testes were dissected and incubated in either 10% neutral buffered formalin (for IHC) or Bouin’s fixative (for hematoxylin and
eosin [H&E] staining) for 8hrs to overnight. Fixed testis was then washed 4 x in 70% ethanol, embed in paraffin and 5 mM sections
mounted on slides. For H&E staining, slides were rehydrated in safeclear followed by decreasing amounts of ethanol. Slides were
then stained with hematoxylin followed by eosin then gradually dehydrated by incubation in increasing concentrations of ethanol.
Finally, slides were mounted using permount and imaged on an Aperio Scanscope.
For immunofluorescence, slides were rehydrated as previously mentioned and then boiled in sodium citrate buffer (10mM Sodium
Citrate, 0.05%Tween 20, pH 6.0) for 20minutes. Following subsequent cooling, slides were blocked in blocking buffer (1 x PBST, 1%
BSA, 3% Goat Serum) for an hour and primary antibody dilutions incubated on the sections overnight at 4C. Slides were then
washed, and incubated with fluorescence-conjugated secondary antibodies for one hour at 37C, washed and then mounted using
a DAPI/Antifademix. Slideswere imaged on a Zeiss Axiophot with Zen 2.0 software. Antibodies used in this study are described in the
Key Resources Table.
Immunohistochemical staining of testis sectionswas similar to that described for immunofluorescent staining, except for the use of
secondary antibodies conjugated to horseradish peroxidase (HRP; Jackson Immunochemicals). HRP detection was achieved using
the Pierce DAB substrate Kit (ThermoFisher Scientific) according to the manufacturers detailed protocol.
Sperm counts
Caudal epididymides of adult mice was transferred and dissected into sperm count media (4% BSA in 1 x PBS). Sample was incu-
bated at 30C for 30 minutes allowing sperm to swim out into the media. 1:10 dilutions were made in 10% neutral buffered formalin
and stored at 4C until counting on a haemocytometer.
Spermatocyte diakinesis spread preparations
Spread diakinesis preparations were made as described in Holloway et al. (2014). Briefly, testis cells were liberated by manual
dissection of tubules in 0.5% KCl. Multiple mixing and slow centrifugation followed by fixation in 30% methanol: 10% acetic acid:
0.05% chloroform. Cells were finally fixed in 30% methanol: 10% acetic acid and then pipette onto heated slides. Finally slides
were stained in using Giemsa and imaged. Slides were imaged on a Zeiss Axiophot with Zen 2.0 software.
Gravitational cell separation (STA-PUT)
Cells were separated using a protocol. The number of adult mice (8-12 weeks, age matched) used in each STA-PUT are as follows:
Figures 3 and 4 and S5: 8 mice of the respective genotypes, Figure 5: 12 mice. Testis extracts were dissected into approximately
30 mL of 1 x Krebs buffer (Sigma K3753) supplemented with amino acids (GIBCO 11130-051, Sigma M7145) and glutaMAX (GIBCO
35050-061) in a Petri dish lid. Extract was incubated in a shaking water bath at 34C, 150rpm in 10mL of 2mg/ml Collagenase (Sigma
C5138) in 1 x Krebs for 15minutes. Following three rounds of centrifugation andwashing in 20mL 1 x Krebs, the testis extract was re-
suspended in 20 mL of 2.5mg/ml Trypsin (Sigma T0303), 200mg/ml DNase (Sigma DN25) in 1 x Krebs and incubated in a shaking
water bath at 34C, 150rpm for 15 minutes. Extract was then centrifuged and washed three times in 20 mL 1 x Krebs, followed by
re-suspension in 20 mL 0.5% BSA (Sigma A7906). Extract was then loaded into the STA-PUT apparatus along with 275 mL 4%
BSA in 1 x Krebs, 275 mL 2% BSA in 1 x Krebs and 100 mL 0.5% BSA in 1 x Krebs. Following loading of the BSA into the separating
chamber along with the extract, the sample was allowed to sediment for 2 hr. Following sedimentation, cell fractions of 13 mL were
collected, centrifuged at 2,000rpm for 5 minutes and washed in 200 ml 1 x PBS. For immunofluorescence analysis of cell types 5 ml of
each fraction was re-suspended in 50mM sucrose and incubated at room temperature for 20 minutes. 30ml drops of 1% Paraformal-
dehyde (EMS 19200) were placed on each well of an 8 well slide and the 50mM sucrose cell mix were added to each well. Slides were
incubated in a humid chamber overnight, followed by drying, washing and staining against proteins defining stages of prophase I, in
our case SYCP3 and gH2AX. The remaining extract was centrifuged at 2,000 rpm for 5 minutes and re-suspended in 1 x PBS Lysis
buffer (1 x PBS, 0.01% NP-40, 5% Glycerol, 150mM NaCl, 1 x Roche cOmplete), sonicated and stored at 20C for downstream
applications.
Protein extraction
Decapsulated testis extract was re-suspended into 1 x PBS Lysis buffer (1 x PBS, 0.01% NP-40, 5% Glycerol, 150mM NaCl, 1 x
Roche cOmplete) and sonicated for 20 s at 22% amplitude in cycles of 0.4 s on and 0.2 s off.
SDS-PAGE and Western Blotting
Protein samples were separated by SDS-PAGE on gels varying in percentage from 6%–14% and transferred to methanol activated
PVDF membranes using a Biorad Mini Trans-Blot Cell. Membranes were incubated in 5% BSA, 1 x TBST for 30minutes to 2 hours at
room temperature while rotating at 60rpm.Membraneswere incubated overnight in primary antibodies in 1 x TBST.Membraneswere
washed three times in 1 x TBST and subsequently incubated for one hour in secondary antibodies in 1 x TBST. Finally membranes
were washed three times in 1 x TBST, developed using the ECL reagent and imaged using a Biorad ChemiDoc imager. Antibodies
used in this study are described in The Key Resources Table.e4 Cell Reports 32, 107858, July 7, 2020
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Protein extracts separated on SDS-PAGE gels were fixed in 40%methanol, 10% acetic acid for 30 minutes. Gels were stained using
the Invitrogen Colloidal Coomassie staining kit (LC6025) in 20%methanol, 20% stainer A, 5% stainer B and incubated at room tem-
perature overnight while slowly rocking. Gels were subsequently washed in double distilled water and imaged.
Image acquisition
Imaging was performed using a Zeiss Axiophot Z1 microscope attached to a cooled charge-coupled device (CCD) Black and White
Camera (Zeiss McM). Images were captured and pseudo-colored using ZEN 2 software (Carl Zeiss AG, Oberkochen. Germany).
Higher resolution images were acquired using an ELYRA 3D-Structured Illumination Super resolution Microscopy (3D-SIM) from
Carl Zeiss with ZEN Black software (Carl Zeiss AG, Oberkochen. Germany). Images are shown as maximum intensity projections
of z stack images. To reconstruct high-resolution images, raw images were computationally processed by ZEN Black. Channel align-
ment was used to correct for chromatic shift. The brightness and contrast of images were adjusted using ImageJ (National Institutes
of Health, USA).
Mass spectrometry and protein identification
Mass spectrometry was performed in the Cornell University Proteomics and Mass Spectrometry facility. The nanoLC-MS/MS anal-
ysis was carried out using an Orbitrap Fusion (Thermo-Fisher Scientific, San Jose, CA) mass spectrometer equipped with a nano-
spray Flex Ion Source using high energy collision dissociation (HCD) and coupled with the UltiMate3000 RSLCnano (Dionex, Sunny-
vale, CA). Each reconstituted sample was injected onto a PepMap C-18 RP nano trap column (3 mm, 100 mm3 20 mm, Dionex) with
nanoViper Fittings at 20 mL/min flow rate for on-line desalting and then separated on a PepMap C-18 RP nano column (3 mm, 75 mm x
25 cm), and eluted in a 120 min gradient of 5% to 35% acetonitrile (ACN) in 0.1% formic acid at 300 nL/min. The instrument was
operated in data-dependent acquisition (DDA) mode using FT mass analyzer for one survey MS scan for selecting precursor ions
followed by 3 s ‘‘Top Speed’’ data-dependent HCD-MS/MS scans in Orbitrap analyzer for precursor peptides with 2-7 charged
ions above a threshold ion count of 10,000 with normalized collision energy of 38.5%. For label-free protein analysis, one MS survey
scanwas followed by 3 s ‘‘Top Speed’’ data-dependent CID ion trapMS/MS scanswith normalized collision energy of 30%. Dynamic
exclusion parameters were set at 1 within 45 s exclusion duration with ± 10 ppm exclusion mass width. All data are acquired under
Xcalibur 3.0 operation software and Orbitrap Fusion Tune 2.0 (Thermo-Fisher Scientific).
All MS and MS/MS raw spectra from each experiment were processed and searched using the Sequest HT search engine within
the Proteome Discoverer 2.2 (PD2.2, Thermo). The default search settings used for relative protein quantitation and protein identi-
fication in PD2.2 searching software were: two mis-cleavage for full trypsin with fixed carbamidomethyl modification of cysteine
and oxidation of methionine and demaidation of asparagine and glutamine and acetylation on N-terminal of protein were used as
variable modifications. Identified peptides were filtered for maximum 1% false discovery rate (FDR) using the Percolator algorithm
in PD 2.2. The relative label free quantification method within Proteome Discoverer 2.2 software was used to calculate the protein
abundances. The intensity values of peptides, which were summed from the intensities values of the number of peptide spectrum
matches (PSMs), were summed to represent the abundance of the proteins. Protein ratios are calculated based on pairwise ratio,
where the median of all possible pairwise ratios calculated between replicates of all connected peptides.
Short-term testis drug culture
Cultures were performed as described elsewhere (Brien˜o-Enrı´quez et al., 2016;Wiltshire et al., 1995), with somemodifications. Testis
extracts were dissected into 1 x PBS and incubated in a shaking water bath at 34C, 150rpm in 2 mg/ml Collagenase (Sigma C5138)
in 1 x PBS for 15 minutes. Following multiple rounds of centrifugation and washing in 1 x PBS, the testis extract was re-suspended in
2.5 mg/ml Trypsin (Sigma T0303), 200 mg/ml DNase (Sigma DN25) in 1 x PBS and incubated in a shaking water bath at 34C, 150rpm
for 15 minutes. Extract was then centrifuged and washed five times in 4 mL spermatocyte culture medium (SCM) (GIBCO DMEM
without red phenol (21063-029), fetal calf serum (GIBCO 10082139), penicillin-streptomycin 1003 (GIBCO 15140-122); lactic acid
(Sigma L13750, NaHCO3 9s8761) and sodium pyruvate 1003 (Sigma 11360-070). Cells were re-suspended in 600ml of SCM and
placed in 12-well treated culture dishes (Corning #3513). Adavosertib (MedChemExpress HY-10993) was diluted in 10% DMSO
and added at 0.25, 0.5, 1, 2, 5 and 10 mg/ml. Nocodazole (Sigma SML1665-1ML) was diluted in 10% DMSO and added at 1, 5,
10, 20, 50 and 80 mg/ml. Cultures were incubated at 37C for 6 hours followed by protein extraction.
QUANTIFICATION AND STATISTICAL ANALYSES
Statistical analyses were performed using GraphPad Prism version 6.00 for Macintosh and Microsoft Excel. Signal intensity of pro-
phase I staged cells from testis tubules (Figure S7) was performed by outlining a minimum of 6 cells per stage and calculating the
average intensity of each channel using ImageJ. Specific analyses are described within the text and the corresponding figures.
Mean values are all presented ± standard deviation (s.d.) and alpha value was established at 0.05. All statistical analyses performed
using two-sided tests.Cell Reports 32, 107858, July 7, 2020 e5
